Originally Posted by
ATC Watcher
PR = Press Release . and reading the contents it is just that.
Press release yes, but this is not just some release to keep up interest in media. Like I said, it’s first results from a phase 3 trial and head of FDA commented:
“The Food and Drug Administration is moving at “lightning speed” to review data on Gilead Sciences Inc.’s experimental Covid-19 treatment remdesivir, Commissioner Stephen Hahn said, after encouraging results emerged from a key U.S. trial.“
Let’s wait for full data to be released and reviewed.
CP